Health · Pharma & Biotech · 51 mins ago
Dong-A launches three ibuprofen-based cold medicines
South Korean drugmaker Dong-A Pharmaceutical has launched three over-the-counter cold medicines called Panpyrin Time Ibuprofen.
They contain ibuprofen, a medicine used to relieve pain and inflammation, and are sold as liquid sachets that can be taken without water.
The three products have different added ingredients to address different cold symptoms, the company said.
They expand Dong-A’s existing Panpyrin range, which was centered on acetaminophen-based products.
The launch follows a change that made it possible to sell ibuprofen-based cold medicines without a prescription in South Korea.
The products are now on the market, but no further details about their availability or sales were given.
Dong-A Pharmaceutical launched three cold medicines based on ibuprofen.
The products are sold under the name Panpyrin Time Ibuprofen.
Each product combines ibuprofen with different additional ingredients to address cold symptoms, the company said.
The liquid stick products can be taken without water.
The launch adds ibuprofen-based products to a Panpyrin range previously centered on acetaminophen.
- Who
- Dong-A Pharmaceutical.
- What
- It launched three ibuprofen-based cold medicines called Panpyrin Time Ibuprofen.
- When
- The company announced the launch on October 12, 2026.
- Where
- Not stated.
- Why
- The launch became possible after over-the-counter cold medicines containing ibuprofen were allowed, the article said.
This story does not have two clearly opposing sides.
No direct quotes in the coverage so far.
This story does not have a timeline yet.
- Products launched
- Three
- Brand name
- Panpyrin Time Ibuprofen
- Main ingredient
- Ibuprofen
- Dosage form
- Liquid stick
- Announcement date
- October 12, 2026
Sources
Related news
Experimental injection reduced visceral fat by 12% in early trials
AstraZeneca blames trial design for failed bone disease drug study
Spain withdraws five erectile dysfunction supplements containing undeclared drugs
Baby Sleep Gripe Water Recalled After Alcohol Found in Testing
FDA Warns Amazon Over Unapproved Herpes Treatments
Possible Wrong Dose Raises Questions for PDE9 Drug Trials in Heart Failure
FDA approves atezolizumab with chemotherapy for some stage III colon cancers
Review links drug company gifts to more and less appropriate prescribing
Brazil suspends Peptistrong supplement and orders all batches recalled
Experimental eye drops improve vision in a small study of a rare eye disease
Taboos limit sales of weight-loss drugs in India despite obesity rates
